UBS Group AG - EYEGATE PHARMACEUTICALS INC ownership

EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M503. A total of 21 filers reported holding EYEGATE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of EYEGATE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,0000.0%3990.0%0.00%
Q2 2021$1,000
-95.2%
399
-90.5%
0.00%
Q1 2021$21,000
+5.0%
4,206
+5.4%
0.00%
Q4 2020$20,000
+900.0%
3,991
+900.3%
0.00%
Q3 2020$2,000
-83.3%
399
-83.5%
0.00%
Q2 2020$12,000
+71.4%
2,416
+67.3%
0.00%
Q1 2020$7,000
+16.7%
1,444
+141.1%
0.00%
Q4 2019$6,000
+200.0%
599
+12.4%
0.00%
Q3 2019$2,0005330.00%
Other shareholders
EYEGATE PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,815,500$8,950,0000.30%
Sterling Financial Planning, Inc. 1,171$6,0000.01%
UBS Group AG 3,991$20,0000.00%
OSAIC HOLDINGS, INC. 468$2,0000.00%
US BANCORP \DE\ 2,710$13,0000.00%
WELLS FARGO & COMPANY/MN 34$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 12,656$62,0000.00%
North Star Investment Management Corp. 20$00.00%
MORGAN STANLEY 466$2,0000.00%
View complete list of EYEGATE PHARMACEUTICALS INC shareholders